Cost · checked August 2026
$159/mo
What one month costs before any prepay discount. The ladders below price each part separately.
Read this first
The $119 you see advertised is the 12-month plan, billing $1,428 today. With no commitment it is $159 a month.
| Plan | Per month | Charged today |
|---|---|---|
| 1-month plan | $159 | $159 |
| 3-month plan | $149 | $447 |
| 6-month plan | $129 | $774 |
| 12-month plan · advertised | $119 | $1,428 |
The product page publishes the ladder as "CHOOSE PLAN 12 mo $228.60/mo $119 /month 12 Month 6 mo $228.60/mo $129 /month 6 month 3 mo $228.60/mo $149 /month 3 Month 1 mo $228.60/mo $159 /month 1 month", and prints each total itself: "Total Price: $2,743.20 $1428", "$1,371.60 $774", "$685.80 $447" and "$228.60 $159". The microdose page carries the identical four prices under a different crossed-out figure of $199.80.
| Plan | Per month | Charged today |
|---|---|---|
| 1-month plan | $249 | $249 |
| 3-month plan | $229 | $687 |
| 6-month plan | $189 | $1,134 |
| 12-month plan | $179 | $2,148 |
Published the same way: "12 mo $349.20/mo $179 /month ... 6 mo $349.20/mo $189 /month ... 3 mo $349.20/mo $229 /month ... 1 mo $349.20/mo $249 /month", with bmiMD's own totals "Total Price: $4,190.40 $2148", "$2,095.20 $1134", "$1,047.60 $687" and "$349.20 $249". The tirzepatide microdose page carries the same four prices against a crossed-out $299.70.
One month of ready-to-ship compounded semaglutide is $159 and one month of tirzepatide is $249. Buy a year and they fall to $119 and $179, which is $1,428 and $2,148 on the card today — bmiMD prints those totals itself. The three- and six-month rungs sit in between.
Now put the full-dose page beside the microdose page. Compounded semaglutide runs $159, $149, $129, $119. Microdose semaglutide runs $159, $149, $129, $119. Tirzepatide runs $249, $229, $189, $179 and microdose tirzepatide runs $249, $229, $189, $179. Identical, rung for rung — they aren't priced differently at all. The only difference between the two pages is the number struck through: $228.60 against $199.80 for semaglutide, $349.20 against $299.70 for tirzepatide. The discount looks bigger on the full-dose page because the crossed-out number is bigger, not because you're paying less.
The home page then prices the same two products twice on one screen. The Best Sellers rail says "Compounded Tirzepatide Starting as low as $349.20/mo $179/mo" and "Compounded Semaglutide Starting as low as $228.60/mo $119/mo"; a Weight loss treatments rail further down the same page says "Compounded Tirzepatide As low as $299.70/mo $179/month" and "Compounded Semaglutide As low as $199.80/mo $119/month". Same products, same day, and the anchors don't match.
The weight-loss page is a separate ladder again, for the personalized plans, and its discount badge does not survive contact with its own numbers. Every row there reads "Save 10% with your subscription", and the two prices beside it are the one-time price and the subscribe price. We checked all twelve rows across the three tables on that page. Three reconcile at exactly ten per cent — $200 to $180, $211 to $189.90, $222 to $199.80. The other nine don't: $283.99 to $228.60 is 19.5 per cent, $362.99 to $299.70 is 17.4 per cent, $219.99 to $189 is 14.1 per cent, and so on down.
One row on that page is simply wrong. Under GLP-1 Microdose, the six-month plan reads "One-Time Purchase $200/month $600 total". Six months at $200 is $1,200. The page's other totals multiply out correctly, which is what makes this one stand out.
The rest of the review — what the service is like and who should skip it — is on the bmiMD review. Prices move; this page was read August 2026, and the company's own site is the current source.
To see every plan above priced out line by line — the rate, any required membership, any published consultation fee, and what a prepay term charges today — use the real cost calculator. It reads the same ladder this page does, so the two cannot disagree.
bmiMD is not a partner. We link to them from the review and earn nothing from it.
More reviews on the index; the rules behind them are on how we review, written by Kevin Turner.